Can AI shrink the billions we spend developing drugs? BioPhy thinks so. It says it knows how to do it.
Related
More from Crazy Stupid Tech
By Om MalikMike McCue, the founder of Flipboard, loves the media. He loves reading, watching, and immersing himself in what other Silicon Valley types derisively think of as “content.” McCue, not surprisingly, has spent the past 15 years creating a way to better consume media digitally. He was at ground zero of the web revolution — he worked at...
By Om Malik I’m addicted to Apple’s Vision Pro. It’s a nearly perfect entertainment device, serving as my ideal television. Sure, I would like it to be lighter. I so badly wish that its battery would last longer. And I wish Siri worked better on it, so that when I ask it a question about what I'm watching (say, how many home runs has Juan Soto...
By Om Malik Pete Warden is the kind of fellow you would run into at the old eTech conference or at Foo Camp—an old-school engineer who is equally at home hacking hardware and writing code in the latest languages. It was at an eTech conference that I first met Warden. I can’t remember the context, but we have been in touch ever since. He would...
By Fred Vogelstein Many still believe AI optimization is an oxymoron. You can’t optimize something as complicated and inherently unpredictable as a neural network. Even if it could be done, what AI chatbot would grant outside companies database access like that? That’s how they’re competing - on the proprietary quality of their data and...
By Om Malik Dennis Crowley has built his career at the intersection of emerging technologies and human behavior. Twenty years ago, as a 25-year-old inspired by Harry Potter's Marauder's Map, he created Dodgeball—turning text messaging into a way for friends to find each other in the city. When the iPhone emerged, he launched Foursquare, riding...